Kerstens, Vera S. http://orcid.org/0000-0002-5770-8419
Varrone, A. http://orcid.org/0000-0001-8281-4435
Funding for this research was provided by:
Karolinska Institutet (2016-00186)
Åhlén-stiftelsen (mA4/h17)
Vetenskapsrådet (2016-02607)
Parkinson Research Foundation
Private donation
AstraZeneca Translational Science Centre at Karolinska Institutet
Article History
Received: 9 July 2020
Accepted: 31 August 2020
First Online: 15 September 2020
Compliance with ethical standards
:
: The PET radioligand [<sup>18</sup>F]FE-PE2I has been developed at Karolinska Institutet in the research group of the authors.
: This article is a review and does not contain new studies on human or animal subjects performed by any of the authors.